A Study of the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of JNJ-47910382 at Different Doses and Dose Regimens in Asian Genotype-1, Chronic, HCV-Infected Patients
Clinical trial NCT01586325 · TERMINATED
Trial details
- NCT number
- NCT01586325
- Sponsor
- Janssen R&D Ireland
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-25
- Primary completion
- 2014-04-21
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.